Press release
Antipsychotic Drugs Market Size to Reach US$ 32.83 Billion by 2032 at 7.9% CAGR Driven by Long-Acting Injectables and Next-Generation CNS Therapies | Next-Generation Muscarinic and Dopamine-Serotonin Targeting Therapies
Antipsychotic Drugs Market
The Global Antipsychotic Drugs Market reached US$ 16.41 billion in 2024 and is expected to reach US$ 32.83 billion by 2032, growing at a CAGR of 7.9% during the forecast period 2025-2032.
DataM Intelligence has published a new research report on "Antipsychotic Drugs Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/antipsychotic-drugs-market?rk
Recent Developments:
✅ October 2025: Johnson & Johnson expanded its long-acting injectable (LAI) antipsychotic portfolio with updated clinical data demonstrating improved relapse prevention in schizophrenia patients. The development strengthens the shift toward extended-duration therapies that enhance treatment adherence and reduce hospitalization rates.
✅ August 2025: Otsuka Pharmaceutical and Lundbeck reported positive Phase III results for a next-generation dopamine-serotonin modulator targeting both schizophrenia and bipolar disorder. The therapy aims to minimize metabolic side effects commonly associated with atypical antipsychotics.
✅ June 2025: Teva Pharmaceutical Industries launched a cost-effective generic version of a widely prescribed atypical antipsychotic in multiple emerging markets, improving affordability and access amid rising mental health diagnoses.
✅ April 2025: Bristol Myers Squibb advanced research on novel muscarinic receptor-targeting antipsychotics designed to address cognitive symptoms in schizophrenia, signaling a move beyond traditional dopamine-centric mechanisms.
Mergers & Acquisitions:
✅ November 2025: AbbVie completed the acquisition of a clinical-stage neuroscience biotech firm to strengthen its central nervous system (CNS) pipeline, including innovative therapies for treatment-resistant schizophrenia.
✅ September 2025: Pfizer acquired a digital therapeutics company focused on schizophrenia management tools, integrating medication with digital adherence and monitoring platforms.
✅ July 2025: Eli Lilly and Company finalized a strategic acquisition of a small-molecule neuropsychiatry developer to expand its long-acting and depot antipsychotic portfolio.
✅ May 2025: Sun Pharmaceutical Industries acquired regional marketing rights for a second-generation antipsychotic in Asia-Pacific markets, reinforcing its presence in branded generics and specialty psychiatry segments.
Key Players:
Dr. Reddy's Laboratories Ltd., Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Alkermes, Eli Lilly and Company, Bristol-Myers Squibb Company, Sumitomo Pharma Co., Ltd. and Pfizer Inc.
Growth Forecast Projected:
The Global Antipsychotic Drugs Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Antipsychotic Drugs Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=antipsychotic-drugs-market?rk
Key Segments:
By Drug Type: First Generation Antipsychotics, Second Generation Antipsychotics, Third Generation Antipsychotics.
By Indication: Schizophrenia, Dementia, , Bipolar disorder, Depression, Others.
By Route of Administration: Oral, Parenteral.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.
Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.
Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.
Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.
Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.
Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.
Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.
Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.
Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/antipsychotic-drugs-market?rk
FAQ
Q1: What is the current size of the Antipsychotic Drugs Market?
A: Global Antipsychotic Drugs Market reached US$ 16.41 billion in 2024 and is expected to reach US$ 32.83 billion by 2032
Q2: How rapidly will the Market expand?
A: The Antipsychotic Drugs market is projected to grow at a CAGR of 7.9% between 2025 and 2032.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?rk
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?rk
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antipsychotic Drugs Market Size to Reach US$ 32.83 Billion by 2032 at 7.9% CAGR Driven by Long-Acting Injectables and Next-Generation CNS Therapies | Next-Generation Muscarinic and Dopamine-Serotonin Targeting Therapies here
News-ID: 4394164 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Green Hydrogen Electrolyzer Market to Reach US$ 17.9 Billion by 2031 Growing at …
The Green Hydrogen Electrolyzer Market reached US$ 2.20 billion in 2023 and is expected to reach US$ 17.9 billion by 2031, growing at a CAGR of 29.9% during the forecast period 2024-2031.
Growth is driven by the rising global focus on decarbonization, clean energy transition, and net-zero emission targets. Increasing investments in green hydrogen production projects, supported by government incentives and policy frameworks, are accelerating the deployment of electrolyzer technologies such…
Gas Chromatography Systems Market to Reach US$7.20 Billion by 2032 at 8.8% CAGR …
The Global Gas Chromatography Systems Market reached US$3,668.75 million in 2024 and is expected to reach US$7,203.59 million by 2032, growing with a CAGR of 8.8% from 2025 to 2032 as demand for advanced analytical instrumentation increases across laboratories and industrial sectors globally.
Growth is supported by rising demand across key applications such as environmental analysis, pharmaceutical testing, food safety and quality control, and petrochemical & chemical analysis, driven by stringent…
Next-Generation Immunotherapy, ADCs, and HER2-Targeted Drugs Transform the Globa …
Esophageal Cancer Treatment Market Size and Forecast
The Global Esophageal Cancer Treatment Market reached US$ 1.31 billion in 2024 and is expected to reach US$ 2.66 billion by 2033, growing at a CAGR of 8.2% during the forecast period 2025-2033.
DataM Intelligence has published a new research report on "Esophageal Cancer Treatment Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business…
Japan Smart Hospitals Market to hit US$ 6.9 billion by 2033 | Major Players 2026 …
The global smart hospitals market size reached US$ 58.82 billion in 2024 is expected to reach US$ 230.94 billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033 as healthcare providers accelerate digital transformation to improve patient outcomes, operational efficiency, and cost‐effectiveness.
Growth is supported by increasing demand across key technologies such as IoT‐enabled medical devices, AI‐driven diagnostics, electronic health records (EHR) integration, telehealth platforms, and robotics,…
More Releases for Antipsychotic
Key Trends Reshaping the Antipsychotic Drugs Market: Advancements In Subcutaneou …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Antipsychotic Drugs Market Size Growth Forecast: What to Expect by 2025?
In recent years, the antipsychotic drugs market has witnessed substantial growth. The market, forecasted to increase from $19.5 billion in 2024 to $21.25 billion in 2025, is expected to have a compound annual growth rate (CAGR) of 9.0%.…
Evolving Market Trends In The Antipsychotic Drugs Industry: Advancements In Subc …
The Antipsychotic Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Antipsychotic Drugs Market Size During the Forecast Period?
The antipsychotic drugs market has grown quickly and is anticipated to increase from $19.5 billion in 2024 to $21.45 billion in 2025 at…
Key Trends Shaping the Future Antipsychotic Drugs Market From 2025-2034: Advance …
What combination of drivers is leading to accelerated growth in the antipsychotic drugs market?
The antipsychotic drug market is anticipated to surge due to the rising prevalence of mental disorders. Mental disorders, also referred to as mental illnesses, affect an individual's thought process, behavior, mood, and overall mental health. These disorders can be influenced by factors such as stress, societal pressures, genetic factors, biochemical imbalance, neurodevelopmental problems, and physical health conditions.…
Antipsychotic Drugs Market Growth An In-Depth Analysis
The global antipsychotic drugs market has shown remarkable growth, with its size estimated at USD 18.04 billion in 2023. Looking ahead, it is projected to reach around USD 37.40 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 7.8% from 2024 to 2032. This growth is driven by increasing awareness and demand for treatments for various psychiatric disorders, alongside advancements in drug formulations and the effectiveness of…
Antipsychotic drugs Market - Restoring Balance, Transforming Lives: Antipsychoti …
Newark, New Castle, USA: The "Antipsychotic drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Antipsychotic drugs Market: https://www.growthplusreports.com/report/antipsychotic-drugs-market/7968
This latest report researches the industry structure, sales, revenue,…
Market Analysis: Antipsychotic Drugs Market on the Rise
The schizophrenia segment emerged dominant in the global antipsychotic drugs market in 2018. The segment had acquired an astonishing 45.2% of the global antipsychotic drugs market share in the same year owing to the rising prevalence of the disorder. This information is published in a report by Fortune Business Insights, titled, "Antipsychotic Drugs: Global Market Analysis, Insights and Forecast, 2019-2026." According to the report, the global market was worth US$…
